Italy: Patients with prostate cancer receiving maximal androgen blockade therapy face a significantly higher risk of bone ...

Androgens can drive prostate cancer growth, thus providing the rationale for using deprivation of androgens as a first line of treatment for prostate cancer. Unfortunately, prostate cancer cells adapt ...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) have glimpsed never-before-seen details of the human androgen receptor — the protein inside of cells that responds to male-typical hormones ...

The androgen receptor is the primary driver of the initiation and growth of prostate cancer, the second-leading cause of death in men. Looking to have a better understanding of how the androgen ...

A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate cancer. In a systematic CRISPR screen, scientists from Arc Institute, UCSF, ...

A summary of the existing avengers in the treatment of metastatic castration-resistant prostate cancer is provided. The goal is to provide a framework to optimize sequencing of existing avengers to ...

Researchers from the University of Otago—Ōtākou Whakaihu Waka have created a world-first epigenetic tool that has implications for medicine, sports, and agriculture. In a study published in the ...

The androgen clock is rewriting the science of aging, offering a precise way to measure hormone exposure and its profound effects on health, longevity, and biology. Study: The androgen clock is an ...